Insider · CIK 0001532219

Quinn Anthony G.

Reports to the SEC for 4 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001532219

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-09	GBIOGeneration Bio Co.U Disposition from Tender	Director	UDisposition from Tender	−29.9K sh	—	—	0
2026-02-09	GBIOGeneration Bio Co.U Disposition from Tender	Director	UDisposition from Tender	−7,283 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,000 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,200 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,500 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,920 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2025-06-04	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2025-01-13	GBIOGeneration Bio Co.P Purchase	Director	PPurchase	+85K sh	$0.97	+$82.5K	299,286
2025-01-10	GBIOGeneration Bio Co.P Purchase	Director	PPurchase	+126K sh	$0.96	+$121K	214,286
2024-06-06	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+60K sh	—	—	60,000
2023-12-01	GBIOGeneration Bio Co.P Purchase	Director	PPurchase	+88.5K sh	$1.41	+$125K	88,495
2023-06-08	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-06-09	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+19.2K sh	—	—	19,200
2022-03-16	SYRESpyre Therapeutics, Inc.P Purchase	Director, President & CEO	PPurchase	+80.1K sh	$2.34	+$188K	550,540
2022-03-15	SYRESpyre Therapeutics, Inc.P Purchase	Director, President & CEO	PPurchase	+42.4K sh	$1.86	+$78.9K	473,461
2022-03-14	SYRESpyre Therapeutics, Inc.P Purchase	Director, President & CEO	PPurchase	+67.5K sh	$1.93	+$130K	431,044
2022-03-11	SYRESpyre Therapeutics, Inc.P Purchase	Director, President & CEO	PPurchase	+34.8K sh	$2.06	+$71.8K	363,572
2022-02-17	SYRESpyre Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President & CEO	AAward	+350K sh	—	—	350,000
2021-12-10	SYRESpyre Therapeutics, Inc.P Purchase	Director, President & CEO	PPurchase	+10.5K sh	$3.75	+$39.5K	328,795
2021-12-09	SYRESpyre Therapeutics, Inc.P Purchase	Director, President & CEO	PPurchase	+43.1K sh	$3.70	+$159K	318,269
2021-10-28	GBIOGeneration Bio Co.G Gift	Director	GGift	−72.8K sh	—	—	0
2021-10-28	GBIOGeneration Bio Co.G Gift	Director	GGift	+72.8K sh	—	—	72,837
2021-10-20	SYRESpyre Therapeutics, Inc.G Gift	Director, President & CEO	GGift	−10K sh	—	—	328,795
2021-10-20	SYRESpyre Therapeutics, Inc.G Gift	Director, President & CEO	GGift	+10K sh	—	—	208,845
2021-10-18	SYRESpyre Therapeutics, Inc.G Gift	Director, President & CEO	GGift	−23.8K sh	—	—	328,795
2021-10-18	SYRESpyre Therapeutics, Inc.G Gift	Director, President & CEO	GGift	+23.8K sh	—	—	208,845
2021-10-14	SYRESpyre Therapeutics, Inc.G Gift	Director, President & CEO	GGift	−175K sh	—	—	328,795
2021-10-14	SYRESpyre Therapeutics, Inc.G Gift	Director, President & CEO	GGift	+175K sh	—	—	208,845
2021-06-30	Kaleido Biosciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-06-09	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-02-17	SYRESpyre Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President & CEO	AAward	+330K sh	—	—	330,000
2020-06-30	Kaleido Biosciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2020-06-16	GBIOGeneration Bio Co.C Conversion	Director	CConversion	+30.4K sh	—	—	72,837
2020-06-16	GBIOGeneration Bio Co. · Series C Preferred StockC Conversion	Director	CConversion	−53.7K sh	—	—	0
2020-06-11	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+52K sh	—	—	52,000
2020-04-30	SYRESpyre Therapeutics, Inc.P Purchase	Director, President & CEO	PPurchase	+165K sh	$4.75	+$784K	538,469
2020-02-14	SYRESpyre Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President & CEO	AAward	+301K sh	—	—	301,000
2019-10-04	SYRESpyre Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+662 sh	$5.46	+$3,614.52	354,305
2019-10-04	SYRESpyre Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+17.6K sh	$6.31	+$111K	371,908
2019-10-04	SYRESpyre Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−662 sh	—	—	0
2019-10-04	SYRESpyre Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−17.6K sh	—	—	119,914
2019-06-14	SYRESpyre Therapeutics, Inc.P Purchase	Director, President & CEO	PPurchase	+5,282 sh	$6.23	+$32.9K	353,643
2019-06-13	SYRESpyre Therapeutics, Inc.P Purchase	Director, President & CEO	PPurchase	+14.4K sh	$6.17	+$88.8K	348,361
2019-06-12	SYRESpyre Therapeutics, Inc.P Purchase	Director, President & CEO	PPurchase	+12.2K sh	$6.11	+$74.7K	333,955
2019-05-22	SYRESpyre Therapeutics, Inc.P Purchase	Director, President & CEO	PPurchase	+3,809 sh	$6.86	+$26.1K	321,738
2019-05-21	SYRESpyre Therapeutics, Inc.P Purchase	Director, President & CEO	PPurchase	+13.8K sh	$6.89	+$95K	317,929
2019-05-20	SYRESpyre Therapeutics, Inc.P Purchase	Director, President & CEO	PPurchase	+8,989 sh	$6.55	+$58.9K	304,135
2019-05-17	SYRESpyre Therapeutics, Inc.P Purchase	Director, President & CEO	PPurchase	+6,218 sh	$6.65	+$41.3K	295,146

Recent filings

Accepted (ET)
Feb 94
Quinn Anthony G.0001104659-26-012194
SEC(opens sec.gov)
Jun 64
Quinn Anthony G.0001415889-25-015958
SEC(opens sec.gov)
Jan 144
Quinn Anthony G.0001415889-25-001417
SEC(opens sec.gov)
Jun 104
Quinn Anthony G.0001415889-24-016184
SEC(opens sec.gov)
Dec 54
Quinn Anthony G.0001415889-23-015857
SEC(opens sec.gov)
Jun 124
Quinn Anthony G.0001415889-23-009609
SEC(opens sec.gov)
Jun 134
Quinn Anthony G.0001415889-22-006475
SEC(opens sec.gov)
Mar 184
Quinn Anthony G.0001209191-22-019929
SEC(opens sec.gov)
Mar 154
Quinn Anthony G.0001209191-22-018942
SEC(opens sec.gov)
Feb 224
Quinn Anthony G.0001209191-22-011724
SEC(opens sec.gov)

Companies

Address

C/O GENERATION BIO CO. 301 BINNEY ST, SUITE 401

CAMBRIDGE, MA, 02142